Esperion Therapeutics Inc ESPR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/27/24 EDT
2.62quote price arrow down-0.08 (-2.96%)
Volume
2,116,477
52 week range
0.70 - 3.34
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.62
  • 52 Week High3.34
  • 52 Week High Date01/12/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23

Key Stats

  • Market Cap484.838M
  • Shares Out185.05M
  • 10 Day Average Volume8.54M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-12.37

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.62
  • 52 Week High3.34
  • 52 Week High Date01/12/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23
  • Market Cap484.838M
  • Shares Out185.05M
  • 10 Day Average Volume8.54M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-12.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.11
  • P/E (TTM)-1.24
  • Fwd P/E (NTM)-3.35
  • EBITDA (TTM)-155.399M
  • ROE (TTM)-260.79%
  • Revenue (TTM)116.334M
  • Gross Margin (TTM)62.81%
  • Net Margin (TTM)-179.87%
  • Debt To Equity (MRQ)-57.49%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Esperion Therapeutics Inc

 

Profile

MORE
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company's NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults...
J. Martin Carroll
Independent Chairman of the Board
Sheldon Koenig
President, Chief Executive Officer, Director
Benjamin Halladay
Chief Financial Officer
Benjamin Looker Esq.
General Counsel
Address
601 21St Street, Suite 300
Vero Beach, FL
32960
United States

Top Peers

SYMBOLLASTCHG%CHG
HROW
Harrow Inc
12.73+0.15+1.19%
SIGA
SIGA Technologies Inc
8.50+0.18+2.16%
AQST
Aquestive Therapeutics Inc
4.10+0.04+0.99%
CDXC
Chromadex Corp
3.67-0.17-4.43%
ALIM
Alimera Sciences Inc
3.90+0.03+0.78%